Syneron Medical Ltd
(ELOS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,830 | -1,520 | N/A | N/A | N/A |
| Depreciation Amortization | 6,440 | 3,930 | N/A | N/A | N/A |
| Other Working Capital | 0 | -7,180 | N/A | N/A | N/A |
| Other Operating Activity | 1,670 | 4,030 | 0 | 0 | 0 |
| Operating Cash Flow | $4,280 | $-740 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,110 | -930 | N/A | N/A | N/A |
| Net Acquisitions | -11,010 | -11,010 | N/A | N/A | N/A |
| Other Investing Activity | 10,550 | 12,690 | 0 | 0 | 0 |
| Investing Cash Flow | $-1,570 | $750 | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 1,250 | 560 | 0 | 0 | 0 |
| Financing Cash Flow | $1,250 | $560 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -820 | 360 | N/A | N/A | N/A |
| Beginning Cash Position | 37,580 | 37,580 | N/A | N/A | N/A |
| End Cash Position | 40,710 | 38,530 | N/A | N/A | N/A |
| Net Cash Flow | $3,120 | $940 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 4,280 | -740 | N/A | N/A | N/A |
| Free Cash Flow | 4,280 | -740 | 0 | 0 | 0 |